Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-01-23
2010-02-16
Coleman, Brenda L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S260100, C514S252160, C544S117000, C544S278000
Reexamination Certificate
active
07662814
ABSTRACT:
New 4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives having the chemical structure of general formula (I), and pharmaceutically acceptable salts thereof are disclosed, as well as processes for their preparation and to pharmaceutical compositions containing them and their use in the treatment, prevention or suppression of pathological conditions, diseases and disorders susceptible of being improved by inhibition of PDE7.
REFERENCES:
patent: 6130223 (2000-10-01), Jonas et al.
patent: 6531498 (2003-03-01), Eggenweiler et al.
patent: 6753340 (2004-06-01), Vergne et al.
patent: 6884800 (2005-04-01), Eggenweiler et al.
patent: 7122565 (2006-10-01), Vergne et al.
patent: 447891 (1991-09-01), None
patent: 0 728 759 (1996-08-01), None
patent: 1329454 (2002-04-01), None
patent: 1329454 (2003-07-01), None
patent: WO98/17668 (1998-04-01), None
Search Report for PCT/EP2004/000584, mailed Jul. 2, 2004.
Search Report for Spanish App lication No. 200300172 dated Jul. 27, 2004 (instant priority document).
esp@cenet Abstract for WO98/17668, published on Apr. 30, 1998.
Martinez, A. et al. “Benzyl Derivatives of 2,1,3-Benzo- and Benzothieno[3,2-a]thiadiazine 2,2-Dioxides: First Phosphodiesterase 7 Inhibitors,”J. Medicinal Chemistry43(4): 683-689 (2000).
Nakata, A. et al. “Potential role of phosphodiesterase 7 in human T cell function: comparative effects fo two phosphodiesterase inhibitors,”Clinical and Experimental Immunology128: 460-466 (2002).
Smith, SJ et al. “Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells,”Am. J. Physiol. Lung Cell Mol. Physiol. 284: L279-L289 (2003).
Alvarez-Builla Gomez Julio
Minguez Ortega Jose Miguel
Segarra Matamoros Victor Manuel
Terricabras Belart Emma
Vaquero Lopez Juan Jose
Coleman Brenda L
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Laboratorios Almirall S.A.
Moore Susanna
LandOfFree
4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4216672